Taylor Riall, MD, PhD, FACS

Chief, Division of Surgical Oncology

Associate Director of Oncology Services

tsriall@surgery.arizona.edu

Links

Biography

Taylor S. Riall, MD, PhD, FACS, is Professor and Chief of the Division of General Surgery and Surgical Oncology at the University of Arizona, College of Medicine – Tucson. Her clinical expertise is in general and pancreaticobiliary surgery, including pancreatic and periampullary cancer, acute and chronic pancreatitis, gallstone disease, gastrointestinal cancer, and general surgery. She has extensive expertise in comparative effectiveness and health services research. Her research has focused on the quality of cancer care and the care of surgical patients. Dr. Riall has been instrumental in developing and implementing critical pathways to streamline care, improve outcomes, and decrease cost of patients undergoing pancreatic, gallbladder, and colorectal surgery.

Cancer Focus

Dr. Riall's clinical focus is on the treatment of hepatobiliary and pancreatic cancers. Her research over the past 20 years has focused on improving surgical outcomes in patients with pancreatic and other GI cancers. Specifically, she uses large administrative datasets to evaluate the quality of cancer care delivered in the US. Her studies have focused on all phases of care cancer from appropriate use of screening, operative and clinical management, to end-of-life care.

Research Program Role

Cancer Prevention and Control Program

Display Name
Taylor Riall, MD, PhD, FACS

Publications

Galouzis N, Khawam M, Alexander EV, Yallourakis MD, Mesropyan L, Luu C, Khreiss MR, Riall TS. 2025. Decision regret and satisfaction with shared decision-making in pancreatic surgery. Journal of Gastrointestinal Surgery. 29(1):101870.

Galouzis N, Khawam M, Alexander EV, Khreiss MR, Luu C, Mesropyan L, Riall TS, Kwass WK, Dull RO. 2024. Pilot Study to Optimize Goal-directed Hemodynamic Management During Pancreatectomy. Journal of Surgical Research. 300:173–182.

Arrington AK, Hsu C-H, Schaefer KL, O’Grady CL, Khreiss M, Riall TS. 2021. Survival after Margin-Positive Resection in the Era of Modern Chemotherapy for Pancreatic Cancer: Do Patients Still Benefit?. Journal of the American College of Surgeons. 233(1):100–109.

Maegawa FB, Ashouri Y, Hamidi M, Hsu C-H, Riall TS. 2021. Gallbladder Cancer Surgery in the United States: Lymphadenectomy Trends and Impact on Survival. Journal of Surgical Research. 258:54–63.

Arrington AK, O’Grady C, Schaefer K, Khreiss M, Riall TS. 2020. Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers. Annals of Surgery. 272(3):438–446.

Arrington AK, Price ET, Golisch K, Riall TS. 2019. Pancreatic Cancer Lymph Node Resection Revisited: A Novel Calculation of Number of Lymph Nodes Required. Journal of the American College of Surgeons. 228(4):662–669.